118 related articles for article (PubMed ID: 37257636)
1. In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study.
Diaz E; Bergqvist C; Peiffer B; Fertitta L; Jannic A; Ferkal S; Zehou O; Hemery F; Sbidian E; Wolkenstein P
J Invest Dermatol; 2023 Dec; 143(12):2408-2415.e7. PubMed ID: 37257636
[TBL] [Abstract][Full Text] [Related]
2. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
3. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
4. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
[TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative malignancies in patients with neurofibromatosis 1.
Bergqvist C; Hemery F; Jannic A; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2021 May; 16(1):230. PubMed ID: 34011343
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
7. Endocrine morbidity in neurofibromatosis 1: a nationwide, register-based cohort study.
Kenborg L; Ebbehoj A; Ejerskov C; Handrup MM; Østergaard JR; Hove H; Doser K; Krøyer A; Mulvihill JJ; Winther JF; Stochholm K
Eur J Endocrinol; 2023 Aug; 189(2):190-198. PubMed ID: 37542520
[TBL] [Abstract][Full Text] [Related]
8. Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.
de Blank P; Li N; Fisher MJ; Ullrich NJ; Bhatia S; Yasui Y; Sklar CA; Leisenring W; Howell R; Oeffinger K; Hardy K; Okcu MF; Gibson TM; Robison LL; Armstrong GT; Krull KR
Genet Med; 2020 Nov; 22(11):1794-1802. PubMed ID: 32572180
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of neurofibromatosis type 1 in the Finnish population.
Kallionpää RA; Uusitalo E; Leppävirta J; Pöyhönen M; Peltonen S; Peltonen J
Genet Med; 2018 Sep; 20(9):1082-1086. PubMed ID: 29215653
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis I and multiple sclerosis.
Bergqvist C; Hemery F; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2020 Jul; 15(1):186. PubMed ID: 32664938
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
[TBL] [Abstract][Full Text] [Related]
12. Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer.
Airewele GE; Sigurdson AJ; Wiley KJ; Frieden BE; Caldarera LW; Riccardi VM; Lewis RA; Chintagumpala MM; Ater JL; Plon SE; Bondy ML
Genet Epidemiol; 2001 Jan; 20(1):75-86. PubMed ID: 11119298
[TBL] [Abstract][Full Text] [Related]
13. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
[TBL] [Abstract][Full Text] [Related]
15. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
16. Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1.
Bhatia S; Chen Y; Wong FL; Hageman L; Smith K; Korf B; Cannon A; Leidy DJ; Paz A; Andress JE; Friedman GK; Metrock K; Neglia JP; Arnold M; Turcotte LM; de Blank P; Leisenring W; Armstrong GT; Robison LL; Clapp DW; Shannon K; Nakamura JL; Fisher MJ
J Clin Oncol; 2019 Nov; 37(32):3050-3058. PubMed ID: 31532722
[TBL] [Abstract][Full Text] [Related]
17. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
Rasmussen SA; Yang Q; Friedman JM
Am J Hum Genet; 2001 May; 68(5):1110-8. PubMed ID: 11283797
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of neurofibromatosis type 1 cancer incidence in the UK.
Walker L; Thompson D; Easton D; Ponder B; Ponder M; Frayling I; Baralle D
Br J Cancer; 2006 Jul; 95(2):233-8. PubMed ID: 16786042
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
20. Anthropometric characteristics and comorbidities in Japanese patients with neurofibromatosis type 1: a single institutional case-control study.
Koga M; Koga K; Nakayama J; Imafuku S
J Dermatol; 2014 Oct; 41(10):885-9. PubMed ID: 25201078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]